Thomas Reinke
Thomas Reinke publishes mostly in Economics and Econometrics, Geriatrics and Gerontology and General Health Professions, on topics such as Pharmaceutical Practices and Patient Outcomes, Pharmaceutical Economics and Policy and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #7,697,969 of 7,710,434 ranked researchers
- Rank in United States
- #1,625,167 of 1,627,098
- Works
- 126
- Citations
- 148
- Citations per work
- 1.2
What does Thomas Reinke research?
Thomas Reinke's work is mostly in Economics, Econometrics and Finance (21%), Medicine (19%), Health Professions (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6148.6%
- Health Sciences3326.4%
- Medicine2419.2%
- Health Professions97.2%
- Social Sciences2721.2%
- Life Sciences53.8%
- 1Economics and Econometrics21% of their works
- 2Geriatrics and Gerontology8% of their works
- 3General Health Professions7% of their works
- 4Public Health, Environmental and Occupational Health6% of their works
- 5Physiology5% of their works
- 6Immunology4% of their works
Research topics
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Primary Care and Health Outcomes
- Healthcare Policy and Management
- Biosimilars and Bioanalytical Methods
- Biomedical Ethics and Regulation
- Economic and Financial Impacts of Cancer
Which keywords describe Thomas Reinke's research?
The keywords of their largest research topics: Primary Care, Inappropriate Medication Use, Polypharmacy, Drug Development Costs, Generic Drugs, Cost-effectiveness Analysis, Quality of Life and Continuity of Care.
- Immunogenicity
- Cost of Care
- Biosimilars
- Insurance Markets
- Continuity of Care
- Cost-effectiveness Analysis
- Drug Development Costs
- Inappropriate Medication Use
- Primary Care
- Polypharmacy
- Generic Drugs
- Quality of Life
- Health Care Spending
- Quality Improvement
- Clinical Trials
- Financial Toxicity
- Stem Cell Regulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Primary Care202 topics
- Inappropriate Medication Use191 topic
- Polypharmacy191 topic
- Drug Development Costs181 topic
- Generic Drugs181 topic
- Cost-effectiveness Analysis121 topic
- Quality of Life121 topic
- Continuity of Care101 topic
- Health Care Spending101 topic
- Insurance Markets101 topic
- Quality Improvement101 topic
- Biosimilars91 topic
- Clinical Trials91 topic
- Cost of Care91 topic
- Financial Toxicity91 topic
- Immunogenicity91 topic
- Stem Cell Regulation91 topic
Where does Thomas Reinke work?
Thomas Reinke's main affiliation in the publication record is Temple University Health System, United States.
How many publications and citations does Thomas Reinke have?
OpenAlex counts 126 works and 148 citations for Thomas Reinke, an h-index of 4, ranking #7,697,969 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas Reinke. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.